Masaya Baba

7.3k citations

117 papers · 5.5k indexed · 1 hit paper · h-index 39

Molecular Biology top 2%
Pulmonary and Respiratory Medicine top 1%
Neurology top 1%
Physiology top 2%
Cancer Research top 1%

Co-authors: Pang‐Hsien Tu John Q. Trojanowski Tatsuo Tomita Kazuyasu Nakaya Takeshi Iwatsubo Shigeo Nakajo W. Marston Linehan Masahiro Yao
Topics: Renal cell carcinoma treatment (32 papers)Renal and related cancers (22 papers)Cancer, Hypoxia, and Metabolism (16 papers)
Cited by: Neurology Cancer Research Pulmonary and Respiratory Medicine
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Nature Communications
Partner nations: Japan United States Belgium

In The Last Decade

Masaya Baba

107 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

1998 1.4k citations Masaya Baba et al. PubMed profile →

Peers

Countries citing papers authored by Masaya Baba

Since Specialization

Citations

This map shows the geographic impact of Masaya Baba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaya Baba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaya Baba more than expected).

Fields of papers citing papers by Masaya Baba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaya Baba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaya Baba. The network helps show where Masaya Baba may publish in the future.

Co-authorship network of co-authors of Masaya Baba

This figure shows the co-authorship network connecting the top 25 collaborators of Masaya Baba. A scholar is included among the top collaborators of Masaya Baba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaya Baba. Masaya Baba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ARID2 Deficiency Enhances Tumor Progression via ERBB3 Signaling in TFE3-Rearranged Renal Cell Carcinoma 2024 ·Current Issues in Molecular Biology ·(unknown),(unknown),(unknown),Seiji Kuroda,Takanobu Motoshima,(unknown),(unknown),Yorifumi Satou,Yuichiro Arima,Hisashi Hasumi,(unknown),Kazuhide Makiyama,Yuichi Oike,Yasuhito Tanaka,Masaya Baba,Tomomi Kamba	0
2	MiT/TFE Family Renal Cell Carcinoma 2023 ·Genes ·(unknown),Masaya Baba	8
3	ANGPTL2 ‐mediated epigenetic repression of MHC‐I in tumor cells accelerates tumor immune evasion 2023 ·Molecular Oncology ·Tsuyoshi Kadomatsu,Chiaki Hara,(unknown),Haruki Horiguchi,Jun Morinaga,Keishi Miyata,(unknown),Hisashi Kanemaru,Satoshi Fukushima,Kimi Araki,Masaya Baba,W. Marston Linehan,Tomomi Kamba,Yuichi Oike	5
4	T1a Renal Cell Carcinoma With Metastasis: Japanese Society of Renal Cancer Retrospective Multi-institute Results 2023 ·Anticancer Research ·(unknown),Cong Wang,Naoya Masumori,Toshinari Yamasaki,Hiroaki Matsumoto,Masaya Baba,Keiichi Ito,(unknown),Hiroshi Kitamura,Masayuki Takahashi,Fumiya Hongo,(unknown),(unknown),Jun‐ichiro Ikeda,Norio Nonomura,Nobuo Shinohara	1
5	The FLCN-TFE3 axis regulates macrophage activation through cellular metabolism 2017 ·Experimental Hematology ·Mitsuhiro ENDO,Masaya Baba,Tamie Endoh,Terumasa Umemoto,Michihiro Hashimoto,Chong Yang,Toshio Suda	1
6	Chronic AMPK activation via loss of FLCN induces functional beige adipose tissue through PGC-1α/ERRα 2016 ·Genes & Development ·Ming Yan,Étienne Audet‐Walsh,Sanaz Manteghi,Catherine R. Dufour,B. E. Walker,Masaya Baba,Julie St‐Pierre,Vincent Giguère,Arnim Pause	86
7	Establishment and characterization of BHD-F59RSVT, an immortalized cell line derived from a renal cell carcinoma in a patient with Birt–Hogg–Dubé syndrome 2016 ·Laboratory Investigation ·Mitsuko Furuya,Hisashi Hasumi,Masaya Baba,Reiko Tanaka,(unknown),(unknown),Yoji Nagashima,Yukio Nakatani,(unknown),Masahiro Yao	2
8	SEROPREVALENCE OF IgG ANTI-T. GONDII ANTIBODY AMONG HIV-INFECTED PATIENTS IN MAIDUGURI, NORTH EASTERN NIGERIA 2012 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Masaya Baba,(unknown)	3
9	Inactivation of the FLCN Tumor Suppressor Gene Induces TFE3 Transcriptional Activity by Increasing Its Nuclear Localization 2010 ·PLoS ONE ·Seung‐Beom Hong,HyoungBin Oh,Vladimir Valera,Masaya Baba,Laura S. Schmidt,W. Marston Linehan	127
10	A three‐gene expression signature model to predict clinical outcome of clear cell renal carcinoma 2008 ·International Journal of Cancer ·Masahiro Yao,Ying Huang,(unknown),Kéiko Hattori,Takayuki Murakami,Futoshi Sano,Masaya Baba,Keiichi Kondo,Noboru Nakaigawa,Takeshi Kishida,Yoji Nagashima,Hisafumi Yamada‐Okabe,Yoshinobu Kubota	39
11	Detection of germline deletions using real‐time quantitative polymerase chain reaction in Japanese patients with von Hippel–Lindau disease 2006 ·Cancer Science ·Kéiko Hattori,Jun‐ichi Teranishi,Catherine A. Stolle,Minoru Yoshida,Keiichi Kondo,Takeshi Kishida,Hiroshi Kanno,Masaya Baba,Yoshinobu Kubota,Masahiro Yao	20
12	Long-term survivors of advanced esophageal cancer without surgical treatment: a multicenter questionnaire survey in Kyushu, Japan 2003 ·Diseases of the Esophagus ·Shoji Natsugoe,Masato Ikeda,Masaya Baba,(unknown),Yoshiyuki Hiraki,M. Nakajo,Takashi Aikou	7
13	PTENMMAC1TEP1 mutations in human primary renal‐cell carcinomas and renal carcinoma cell lines 2001 ·International Journal of Cancer ·Keiichi Kondo,Masahiro Yao,Kazuki Kobayashi,S. Ota,Minoru Yoshida,Shigeki Kaneko,Masaya Baba,Naoki Sakai,Takeshi Kishida,Satoshi Kawakami,Hiroji Uemura,Yoji Nagashima,Yukio Nakatani,Masahiko Hosaka	70
14	Induction of SPARC by VEGF in Human Vascular Endothelial Cells 2001 ·Biochemical and Biophysical Research Communications ·Yukio Kato,Jean-Marc Lewalle,Yuh Baba,Mamoru Tsukuda,Naoki Sakai,Masaya Baba,Kazuki Kobayashi,(unknown),Yoji Nagashima,Françis Frankenne,Agnès Noël,Jean‐Michel Foidart,Ryu‐Ichiro Hata	52
15	Germ‐line Mutation Analysis in Patients with von Hippel‐Lindau Disease in Japan: An Extended Study of 77 Families 2000 ·Japanese Journal of Cancer Research ·Minoru Yoshida,Shingo Ashida,Keiichi Kondo,Kazuki Kobayashi,Hiroshi Kanno,Nobuo Shinohara,Nobuyuki Shitara,Takeshi Kishida,Satoshi Kawakami,Masaya Baba,Isao Yamamoto,Masahiko Hosaka,Taro Shuin,Masahiro Yao	47
16	MAPK Upstream Kinase (MUK)-binding Inhibitory Protein, a Negative Regulator of MUK/Dual Leucine Zipper-bearing Kinase/Leucine Zipper Protein Kinase 2000 ·Journal of Biological Chemistry ·(unknown),Michihiko Yoshida,Akio Yamashita,(unknown),Masaya Baba,Atsushi Suzuki,Hiroshi Mohri,Zenrō Ikezawa,Hiroshi Nakajima,Syu-ichi Hirai,Shigeo Ohno	38
17	Direct Interaction of the β-Domain of VHL Tumor Suppressor Protein with the Regulatory Domain of Atypical PKC Isotypes 1999 ·Biochemical and Biophysical Research Communications ·Heiwa Okuda,Syu-ichi Hirai,Yasuyuki Takaki,Masayuki Kamada,Masaya Baba,Naoki Sakai,Takeshi Kishida,Shigeki Kaneko,Masahiro Yao,Shigeo Ohno,Taro Shuin	72
18	Prevention of asthma by ketotifen in infants with atopic dermatitis. 1992 ·PubMed ·Yoji Iíkura,Charles K. Naspitz,Haruki Mikawa,(unknown),Masaya Baba,Dirceu Solé,Sankei Nishima	102
19	Synthesis and anti-HIV activity of different sugar-modified pyrimidine and purine nucleosides 1988 ·Journal of Medicinal Chemistry ·Piet Herdewijn,Jan Balzarini,Masaya Baba,Rudi Pauwels,Arthur Van Aerschot,(unknown),Erik De Clercq	108
20	[Cystic craniopharyngioma extending down into the upper cervical spinal canal (author's transl)]. 1978 ·PubMed ·Masaya Baba,(unknown),M. Jimbo,(unknown)	18

About Masaya Baba

Masaya Baba is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 117 papers that have together received 5.5k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (32 papers), Renal and related cancers (22 papers) and Cancer, Hypoxia, and Metabolism (16 papers). The work is most often cited by research in Neurology (1.2k citations), Cancer Research (1.1k citations) and Pulmonary and Respiratory Medicine (1.6k citations). Masaya Baba has collaborated with scholars based in Japan, United States and Belgium. Frequent co-authors include Pang‐Hsien Tu, John Q. Trojanowski, Tatsuo Tomita, Kazuyasu Nakaya, Takeshi Iwatsubo, Shigeo Nakajo, W. Marston Linehan, Masahiro Yao, Seung‐Beom Hong and Laura S. Schmidt. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact